Insulet: On A Sugar High With Downside Of 30% Or More
- The number of new entrants has increased the competition significantly.
- The effect of future Dilution on valuation.
- The Medtronic patent infringement settlement eliminates a significant competitive advantage.
- Alternative products coming to the market such as the Artificial Pancreas and inhaled drugs.
- The market opportunity is being overplayed.